Thermo Fisher Scientific Inc. and TransMIT GmbH Center for Mass Spectrometric Developments have entered a co-marketing agreement to promote the use of a mass spectrometry imaging (MSI) platform for spatial multi-omics applications in pharma and clinical labs.   As part of the relationship, TransMIT will combine its proprietary scanning microprobe matrix-assisted laser desorption/ionization (SMALDI) MSI and 3D-surface MSI technology with the high resolution accurate mass (HRAM) power of Thermo ...